LSERS
ITOS

Louisiana State Employees Retirement System’s iTeos Therapeutics ITOS Stock Holding History

Louisiana State Employees Retirement System’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,500
Closed -$148K – 1529
2023
Q3 		$148K Buy
13,500
+500
+4% +$6.39K ﹤0.01% 1515
2023
Q2 		$172K Buy
13,000
+1,600
+14% +$22.8K ﹤0.01% 1513
2023
Q1 		$155K Sell
11,400
-300
-3% -$5.38K ﹤0.01% 1489
2022
Q4 		$229K Hold
11,700
– – 0.01% 1457
2022
Q3 		$223K Buy
11,700
+1,900
+19% +$43.8K 0.01% 1442
2022
Q2 		$258K Hold
9,800
– – 0.01% 1442
2022
Q1 		$304K Buy
+9,800
New +$356K 0.01% 1437

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Louisiana State Employees Retirement System's ITOS Position: Q4 2023 in Review

Louisiana State Employees Retirement System sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 13,500 shares — an estimated $148K sold.

Louisiana State Employees Retirement System first reported a position in ITOS in Q1 2022 and held it in 7 quarters. The position peaked at $304K in Q1 2022. 138 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • Louisiana State Employees Retirement System reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 13,500 iTeos Therapeutics shares in Q4 2023, an estimated $148K.
  • Louisiana State Employees Retirement System first reported a position in iTeos Therapeutics in Q1 2022 and held it in 7 quarters.
  • Louisiana State Employees Retirement System's iTeos Therapeutics position peaked at $304K in Q1 2022.
  • 138 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on Louisiana State Employees Retirement System's 13F filing for Q4 2023, filed 29 Jan 2024.